The invention provides an Aβ peptide aggregation inhibitor, an Aβ peptide toxicity reducing agent, and a preventive and/or therapeutic agent for Alzheimer's disease. The oxidized Aβ peptide in which one or more amino acid residues of Aβ peptide have been oxidized (excluding an oxidized Aβ peptide in which only Met has been oxidized).
本发明提供了一种 Aβ 肽聚集
抑制剂、一种 Aβ 肽毒性降低剂以及一种阿尔茨海默病的预防和/或治疗剂。氧化 Aβ 肽,其中 Aβ 肽的一个或多个
氨基酸残基被氧化(不包括仅 Met 被氧化的氧化 Aβ 肽)。